Products

Glytec Glucommander
Glytec, LLC
Clinical Decision Support & Reference
Glytec Glucommander is an FDA-cleared, AI-driven, cloud-based insulin management software that provides clinical decision support and personalized insulin dosing recommendations for both IV and subcutaneous insulin therapy in hospitals and health systems. It is part of the broader GlytecOne platform, which offers intelligent glycemic management solutions to improve patient safety, reduce complications, and drive better patient outcomes.

See all 1 product →

About Glytec

Glytec is a leading healthcare AI company specializing in intelligent glycemic management. Their flagship product, Glucommander®, is an FDA-cleared, cloud-based insulin dosing software that leverages real-time and historical patient data to provide personalized IV and subcutaneous insulin dosing recommendations for adult and pediatric patients (ages 2-17 years). This AI-powered platform aims to improve patient safety, reduce readmissions, and streamline clinical workflows in hospitals and health systems. Glytec’s solutions are designed to move beyond manual protocols and sliding-scale dosing, offering validated guidance to clinicians and supporting confident insulin management decisions.

For physicians, GlytecOne, the unified insulin management platform, offers several key benefits. It provides FDA-cleared point-of-care dosing guidance for both IV and subcutaneous insulin through Glucommander®, helping to reduce variability and support safer decisions at the bedside. The platform also includes Command Center, which offers current patient data displays to help identify emerging patterns and areas needing clinical review, as well as enterprise-level analytics for leaders to review trends and identify areas for improvement. Glytec’s system integrates with major electronic health record (EHR) platforms like Epic and Cerner, aiming to simplify workflows for providers, nurses, and pharmacists, and offering enhanced features for IV to SubQ insulin transition and hypoglycemia management. The company emphasizes that Intelligent Glycemic Management supports, rather than replaces, clinical judgment.

Focus Areas

AI-powered diabetes management insulin dosing software glycemic management clinical decision support workflow automation performance analytics population health intelligence inpatient and outpatient care.

Business Intelligence

TechnologyCloud-based SaaS solution, AI-powered technology platform, integrates with EHRs (Epic, Oracle Health (Cerner), Meditech), FDA-cleared Class II Software as a Medical Device (SaMD), HIPAA compliant, HITRUST certified

What Physicians Need to Know

AI-Powered Insulin Dosing Software (Glucommanderu00ae)
Glytec's flagship product, Glucommanderu00ae, is an FDA-cleared, cloud-based software that provides personalized IV and subcutaneous insulin dosing recommendations for adult and pediatric (ages 2-17 years) patients. It uses real-time and historical patient data to learn insulin sensitivity and predict future needs, replacing outdated manual protocols and sliding-scale insulin.
Intelligent Glycemic Management Platform (GlytecOneu2122)
GlytecOne is a unified platform integrating clinical decision support, care workflow automation, performance analytics, and population health insights. It aims to deliver safer, smarter glucose management across the entire health system, from inpatient to outpatient settings.
Clinical Decision Support
The platform's Decision Support layer, including Command Center, organizes and displays current and retrospective patient glucose data and evidence-based information to support clinician awareness, prioritization, and informed clinical review. It's purpose-built for glucose management, reducing alert fatigue by presenting context-specific data.
Workflow Automation
GlytecOne streamlines clinical workflows by automating time-consuming, error-prone steps in glycemic protocol management. This includes automated protocol workflow and documentation support, pharmacy-integrated order review tools, and built-in audit trails. It also offers features like single sign-on (SmartClicku2122) and automated reminders for blood glucose checks.
Performance Analytics (GlucoMetricsu00ae)
Glytec's Performance Insights, delivered through Command Center and GlucoMetricsu00ae, provide enterprise-level analytics and performance intelligence. It aggregates glycemic data across the health system, offering actionable dashboards, benchmarks, and improvement roadmaps, including KPI dashboards, automated benchmarking, and eCQM-aligned reporting modules for CMS compliance.
Population Health Intelligence
GlytecOne's Population Health solution aggregates outcomes for all facilities and care settings, providing enterprise-wide glycemic performance intelligence. This supports systemic improvements in glycemic management at scale across the entire health system, including eCQM alignment, value-based care reporting, and health plan partnerships.
Inpatient and Outpatient Care
Glytec's solutions support glycemic management across the continuum of care, including IV, subcutaneous (SubQ), and outpatient insulin management, as well as transitions between these stages.
Physician Tip

Glytec's Glucommanderu00ae offers personalized, evidence-based insulin dosing recommendations, reducing the burden of manual calculations and minimizing errors. The system provides real-time visibility into patient glucose data through Command Center, helping physicians prioritize and make informed decisions. Workflow automation and EHR integration streamline documentation and reduce administrative tasks, freeing up time for direct patient care. The platform's analytics capabilities (GlucoMetricsu00ae) allow for tracking key performance indicators and identifying areas for improvement in glycemic control across patient populations, which is crucial for value-based care and CMS compliance. Glytec's solutions have demonstrated significant reductions in severe hypoglycemia, length of stay, and readmissions.

GlytecOne is designed for seamless, bi-directional integration with major Electronic Health Record (EHR) systems, including Epic, Oracle Health (Cerner), and Meditech. This integration ensures clinical data flows cleanly, documentation remains within the EHR, and reduces the need for duplicate data entry. The platform utilizes an HL7 interface for standard data exchange protocols.

Products by Glytec

1 product in the directory

Glytec Glucommander
Glytec, LLC
Clinical Decision Support & Reference
Glytec Glucommander is an FDA-cleared, AI-driven, cloud-based insulin management software that provides clinical decision support and personalized insulin dosing recommendations for both IV and subcutaneous insulin therapy in hospitals and health systems. It is part of the broader GlytecOne platform, which offers intelligent glycemic management solutions to improve patient safety, reduce complications, and drive better patient outcomes.

What the Web Says

Glytec is generally well-regarded for its glycemic management software, particularly for insulin dosing support in hospital settings. Reviews highlight its effectiveness in improving patient outcomes and reducing hypoglycemia. As an employer, opinions are more mixed, with some praising the culture and mission, while others point to challenges common in smaller, growing companies.

Overall: Mixed

Strengths

  • Effective in improving glycemic control and reducing adverse events like hypoglycemia.
  • Provides strong clinical decision support for insulin dosing.
  • User-friendly interface for healthcare professionals.
  • Dedicated and knowledgeable customer support.
  • Positive impact on patient safety and hospital efficiency.
  • Strong company mission and commitment to improving diabetes care.

Limitations

  • Integration with existing EHR systems can sometimes be challenging or require significant effort.
  • Some users report a learning curve for new staff.
  • Pricing can be a concern for smaller institutions.
  • As an employer, some reviews mention typical challenges of a smaller company, such as resource constraints or rapid change.
  • Limited public reviews on certain platforms (e.g., Reddit) specifically for product experiences.
  • Specific features or customization options might be desired by some users.

Based on reviews from: G2, Glassdoor, Capterra, KLAS Research (indirect references), Healthcare IT News (indirect references), Reddit (limited mentions)

Last updated: 2026-09-22

Videos

News, demos, and interviews about Glytec.

Loading videos...

Videos load interactively. If none appear, search YouTube for Glytec →

View all on YouTube

Press & Coverage

Glytec
Glytec Secures $36 Million Growth Investment to Accelerate AI-Powered Diabetes Technology Platform Innovation
Glytec announced a $36 million growth investment led by Savitr Capital and Hayfin Capital Management to expand its AI-powered diabetes technology platform, including its Glucommanderu00ae SaaS solution, and accelerate new technology development to address the global diabetes crisis.
2025-06
Glytec
Glytec Named Top Diabetes Management Platform for 2025
Healthcare Tech Outlook recognized Glytec as its Top Diabetes Management Platform for 2025, an award that highlights technologies advancing patient safety, streamlining clinical workflows, and delivering measurable outcomes at scale.
2025-09
Glytec
KLAS Recognizes Glytec Glucommanderu00ae for Advancing Inpatient Glycemic Management
A KLAS First Look report highlighted Glytec's Glucommanderu00ae for improving patient safety, insulin dosing accuracy, and reducing hypoglycemia in inpatient glycemic management.
2025-11
Glytec
The Final Countdown for New CMS Glycemic Measures: Glytec Prepares Hospitals and Health Systems with Proven, FDA-Cleared Technology Platform
Glytec is supporting U.S. hospitals in preparing for the upcoming Centers for Medicare & Medicaid Services (CMS) mandate on inpatient glycemic control reporting, which begins January 1, 2026, and requires reporting of severe hypoglycemia and hyperglycemia.
2025-07
Glytec
Glytec Advances Market Leadership in Critical Time for the Hospital Industry
Glytec reported a record year in 2024, increasing its customer base and achieving significant reductions in hypoglycemia rates and millions in savings for clients, positioning them for new CMS reporting requirements.
2025-02
Glytec
Glytec Expands Global Collaboration with Roche to Revolutionize Hospital Diabetes Management
Glytec announced an expanded collaboration with Roche to integrate Glytec's insulin management software with Roche's cobasu00ae pulse smart-device hospital blood glucose system in US and worldwide markets.
2024-08
Glytec
Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States
This retrospective observational study evaluated glycemic and clinical outcomes in COVID-19 patients with and without diabetes and/or acutely uncontrolled hyperglycemia, finding that these conditions were frequent and associated with higher mortality and longer hospital stays.
2020-04
Glytec
Glytec raises $21M for insulin dosing management tech
Glytec secured $21 million in financing, comprising $9 million in debt from Silicon Valley Bank and $12 million in equity led by Savitr, to advance its eGlycemic Management System (eGMS) and expand its workforce.
2021-05

Frequently Asked Questions

Glytec's core product is GlytecOne, an intelligent glycemic management platform. At its heart is Glucommander, an FDA-cleared, AI-powered insulin dosing software that provides personalized IV and subcutaneous insulin recommendations. It uses real-time and historical patient data to learn insulin sensitivity and predict future needs, aiming to reduce errors and improve patient outcomes.
GlytecOne offers a unified platform for both inpatient and outpatient care, integrating clinical decision support, workflow automation, and performance analytics. For clinicians, it provides algorithm-based insulin dosing guidance, automated protocol workflows, and pharmacy-integrated order review tools, which streamline processes and reduce manual errors. The system also offers current patient visibility and structured clinical review through its Command Center, helping clinicians make informed decisions.
GlytecOne includes Performance Insights and Population Health intelligence. Performance Insights, delivered via the Command Center, provides enterprise analytics, benchmarking, and eCQM-aligned reporting to measure and improve glycemic performance across the health system. Population Health aggregates glycemic data, outcomes, and analytics across all facilities and care settings, offering enterprise-level intelligence for managing outcomes, regulatory compliance, and financial performance.
Glytec's Glucommander is an FDA-cleared Class II Software as a Medical Device (SaMD), ensuring rigorous testing and validation. The entire GlytecOne platform is HIPAA compliant and HITRUST certified, meaning it adheres to strict information security and risk management requirements to protect patient data.
Glytec offers 24/7 clinical and technical support for Severity 1 issues, with routine support available during business hours for other issues. The company has been recognized as a top diabetes management platform and has secured significant growth investments, indicating strong company stability. Glytec also has strategic partnerships with health systems like TidalHealth and Ardent Health, and collaborations with companies like Roche, to expand its reach and integrate its solutions.
While specific pricing details are not publicly disclosed, annual licensing fees for Glytec's platform typically include software implementation, team training, and ongoing technical and clinical support.
Glytec's solutions are designed to help hospitals meet the upcoming CMS glycemic management mandates, which begin in fiscal year 2026 (October 1, 2025). Their platform provides advanced analytics for actionable insights and eCQM-aligned reporting to support compliance with these new mandatory electronic clinical quality measures (eCQMs).

Related Companies

A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]

OpenAI is an American artificial intelligence (AI) company that conducts research and develops advanced AI models. While widely known for its generative AI models like ChatGPT and DALL-E, OpenAI has significantly expanded its focus into the healthcare sector. The company’s mission is to ensure that artificial general intelligence (AGI) benefits all of humanity, and this […]

The Utah Medical Licensing Board is a state governmental agency responsible for regulating the licensing and practice of medical professionals within Utah. It operates under the Utah Division of Professional Licensing (DOPL), which is part of the Department of Commerce. The Board’s primary function is to ensure the health and safety of Utah citizens by […]

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]

The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.